Myelodysplastic syndromes: open trials in Japan

9 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07422480
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
Trial Treatment · Phase 3 · Takeda
Hyogo Prefectural Amagasaki General Medical Center, Amagasaki-shi · Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyō-Ku · Fukushima Medical University Hospital, Fukushima · Chugoku Central Hospital, Fukuyama-shi · Gifu Municipal Hospital, Gifu · Dokkyo Medical University Hospital, Mibu · NHO Nagoya Medical Center, Nagoya · NTT Medical Center Tokyo, Shinagawa-ku
Registry updated 2026-11-06
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
National Hospital Organization Nagoya Medical Center, Nagoya · The Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT07319845
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Trial Treatment · Phase 2 · Takeda
National Hospital Organization Nagoya Medical Center, Aichi · Japanese Red Cross Narita Hospital, Chiba · Matsuyama Red Cross Hospital, Ehime · University of Fukui Hospital, Fukui · JCHO Kyushu Hospital, Fukuoka · National Hospital Organization Kyushu Medical Center, Fukuoka · Gifu Municipal Hospital, Gifu · Japan Mutual Aid Association of Public School Teachers Chugoku Central Hospital, Hiroshima · Hokuyukai Sapporo Hokuyu Hospital, Hokkaido · Kobe City Hospital Organization Kobe City Medical Center General Hospital, Hyōgo · Tokai University Hospital, Kanagawa · Kitasato University hospital, Kanagawa · National University Corporation Tohoku University Tohoku University Hospital, Miyagi · Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki · Okayama City General Medical Center Okayama City Hospital, Okayama · Kindai University Hospital, Osaka · Dokkyo Medical University Hospital, Tochigi · NTT Medical Center Tokyo, Tokyo · Tokyo Metropolitan Komagome Hospital, Tokyo · Yamagata University Hospital, Yamagata · Yamanashi Prefectural Central Hospital, Yamanashi
Registry updated 2026-10-28
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Kashiwa · Okayama
Registry updated 2026-10-23
NCT06782373
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Trial Treatment · Phase 2 · Swedish Orphan Biovitrum
Fukushima Medical University Hospital, Fukushima · Nagasaki University Hospital, Nagasaki · Yokohama City University Hospital, Yokohama
Registry updated 2026-10-16
NCT06465953
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Trial Treatment · Phase 3 · Institut de Recherches Internationales Servier
Kyushu University Hospital, Higashi-ku, Fukuoka-city, Fukuoka · Japanese Red Cross Society Himeji Hospital, Himeji-city, Hyogo · Tokai University Hospital, Isehara City, Kanagawa · Japanese Red Cross Musashino Hospital, Musashino-city, Tokyo · Kitasato University Hospital, Sagamihara · University of Fukui Hospital, Yoshida-gun
Registry updated 2026-09-03
NCT04608110
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
Trial Treatment · Phase 1 · Taiho Pharmaceutical Co., Ltd.
Nippon Medical School Hospital, Bunkyō City · Fukushima Medical University Hospital, Fukushima · Saitama Medical University Hospital, Iruma · University Hospital Kyoto Prefectural University of Medicine, Kyoto · Nagasaki University Hospital, Nagasaki · Osaka City General Hospital, Osaka · Kindai University Hospital, Sakai · NTT Medical Center Tokyo, Shinagawa-ku · Tokyo Medical University Hospital, Shinjuku-ku · Yamagata University Hospital, Yamagata
Registry updated 2026-08-10
NCT04064060
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Trial Treatment · Phase 3 · Celgene
Chiba · Japanese Red Cross Society Himeji Hospital, Himeji · Hitachi · Shonan Kamakura General Hospital, Kamakura · Kamogawa · Matsuyama Red Cross Hospital, Matsuyama · Nagasaki · Nagoya · Ogaki Municipal Hospital, Ōgaki · Osaka · Sagamihara · Sakai · Sendai · Sendai · Shibuya City · NTT Medical Center Tokyo, Shinagawa City
Registry updated 2026-07-01
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
Tokyo Metropolitan Komagome Hospital, Bunkyō City · Nippon Medical School Hospital, Bunkyo-ku · Kyushu University Hospital, Fukuoka · Fukushima Medical University Hospital, Fukushima · Hokkaido University Hospital, Hokkaido · Tokai University Hospital, Isehara-Shi · National Cancer Center Hospital East, Kashiwa-shi · Tohoku University Hospital, Miyagi · Nagasaki University Hospital, Nagasaki · Okayama University Hospital, Okayama · Osaka University Hospital, Osaka · University of Fukui Hospital, Yoshida-gun
Registry updated 2026-03-24

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error